Form 8-K - Current report:
SEC Accession No. 0001104659-26-059700
Filing Date
2026-05-13
Accepted
2026-05-13 06:14:34
Documents
13
Period of Report
2026-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2614295d1_8k.htm   iXBRL 8-K 35259
2 EXHIBIT 99.1 tm2614295d1_ex99-1.htm EX-99.1 66456
6 GRAPHIC image_001.jpg GRAPHIC 2881
  Complete submission text file 0001104659-26-059700.txt   288256

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zbio-20260511.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zbio-20260511_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zbio-20260511_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2614295d1_8k_htm.xml XML 3322
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42270 | Film No.: 26970789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)